Prothena reported $-0.68 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Agios Pharmaceuticals USD -1.78 0.15 Sep/2025
ALKERMES USD 0.49 0.03 Sep/2025
Alnylam Pharmaceuticals USD 2.9 2.58 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 4.81 0.66 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Exelixis USD 0.78 0.03 Sep/2025
Incyte USD 2.26 0.69 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
MacroGenics USD 0.27 0.84 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
Prothena USD -0.68 1.66 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Ultragenyx Pharmaceutical USD -1.81 0.64 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025